Research
Hormonal
Discontinuation of anti-obesity medications leads to significant weight regain (approx. 6.9% of lost weight) and return of hunger, indicating AOMs are for chronic management, not short-term fixes.
Do not view these medications as a 6-month fix. They are chronic treatments. If you stop, your biology will push you to regain weight. Plan for long-term use or have a robust maintenance strategy if you must stop, understanding the high risk of regain.
GoodSupportsHIGH confidence
There is evidence that once an AOM is stopped, even with an adjunct lifestyle program, patients regained 6.9% of the weight lost.
Why this rating
Cites specific clinical trial data (STEP 4).
Source
Exercise for Clients Taking an Anti-Obesity Medication
Renee J. Rogers · ACSMʼs Health & Fitness Journal · 2024
DOI 10.1249/fit.0000000000000959
narrative_reviewCited 13×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Contemporary NuSH anti-obesity medications (semaglutide, tirzepatide) produce significantly greater weight loss than intensive lifestyle interventions alone.Strong
- Exercise prescriptions for clients taking anti-obesity medications (AOMs) should be reframed from caloric expenditure to focus on health, well-being, and functional targets (strength, aerobic fitness, body awareness) rather than enhancing weight loss.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →